Tuesday, October 20, 2020 9:56:08 AM
(EYEG)Float 2M-about TO EXPLODE --MC $17 M--Float 2 M -Fiing for US approval for BIG Eye Drug expected this Quarter / Share price $3.65 ...Stock could explode back to $10++ again
"In the second half of 2020, we anticipate several important milestones, including the completion of testing required to use cost-effective OBG packaging in the PE pivotal study, the filing of the IDE for our PE pivotal study, and the submission of the de novo application for commercialization of our OBG eye drop in patients who have undergone PRK surgery."
Presentation
https://file///C:/Users/berns/AppData/Local/Temp/EyeGate-Corporate-Presentation-Sept-2020-1.pdf
EYEG: Raising Target on positive pipeline progress....September 28, 2020
https://finance.yahoo.com/news/eyeg-raising-target-positive-pipeline-150500023.html
Based on the Company’s positive progress, we are raising our valuation from $12.00 to $15.00 based on a 10-year DCF with terminal market shares of 15-20% in the US for both its PRK and PE products, 20% royalties, 10% discount rate, 20% terminal EBIT margin, 25% tax rate and $6 million in net cash.
"In the second half of 2020, we anticipate several important milestones, including the completion of testing required to use cost-effective OBG packaging in the PE pivotal study, the filing of the IDE for our PE pivotal study, and the submission of the de novo application for commercialization of our OBG eye drop in patients who have undergone PRK surgery."
Presentation
https://file///C:/Users/berns/AppData/Local/Temp/EyeGate-Corporate-Presentation-Sept-2020-1.pdf
EYEG: Raising Target on positive pipeline progress....September 28, 2020
https://finance.yahoo.com/news/eyeg-raising-target-positive-pipeline-150500023.html
Based on the Company’s positive progress, we are raising our valuation from $12.00 to $15.00 based on a 10-year DCF with terminal market shares of 15-20% in the US for both its PRK and PE products, 20% royalties, 10% discount rate, 20% terminal EBIT margin, 25% tax rate and $6 million in net cash.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
